We’re thrilled to share our Nature Methods review on #CellPainting — your go-to resource for mastering Cell Painting! From MOA and toxicity prediction to contributing to candidate drugs in clinical trials, we’ve distilled 10 years of insights! Free link: rdcu.be/d2vHH

NCT06445062: Revolution Medicines trial combining RMC-6236 with either FOLFIRINOX or Gemcitabine/nab-paclitaxel in treatment naive #PancreaticCancer. This study is now open at 17 locations nationwide. Also includes sub-cohorts for #ColorectalCancer and 2nd line pancreatic cancer.

Day after Christmas blockbuster from @HCCvPDAC with Kathy DelGiorno, Dr. Nina Steele Dr. Brittany Allen-Petersen and colleagues in Developmental Cell. 1st author Daniel Sålas-Escabillas 🇬🇺🌈👨🏽‍🔬 (They/Them) (now in Laura DeLong Wood lab) scores a dynamite (TNT!). Tuft cells are not found in the normal pancreas, how up in

Full policy announcement here: grants.nih.gov/grants/guide/n…

Thank you Sungmin Nam University of Michigan Mechanical Engineering for your exceptional CPOD talk! Your research & expertise was enlightening & engaging & captivated the audience. Thank you for sharing your knowledge & being part of our seminar series! #GoBlueMed

Fine, here we go. First let's start with some baseline expectations. Pancreatic cancer is scary, 5y survival is ~10%. So if you see a trial with an apparent survival asymptote at ~50% then certainly *something* is happening, right?

Join Us and Our Team on April 26th! The Rogel and Blondy Center for Pancreatic Cancer. U-M Rogel Cancer Center PanCAN timofran Lyssiotis Lab secure.pancan.org/site/TR/Purple…

Join our Rogel and Blondy Center for Pancreatic Cancer team at the Purple Strides walk to support Michigan - Pancreatic Cancer Action Network

Premier Sponsor Alert! A heartfelt thank you to Rogel and Blondy Center for pancreatic cancer research for their generous Premier Sponsorship of PurpleStride Michigan 2025. #pancreaticcancerresearch Rogel and Blondy Center for Pancreatic Cancer Learn more and join us at purplestride.org/Michigan

Hey there! Our paper on ecDNA in pancreatic cancer is online nature.com/articles/s4158…. Thankful to our amazing friends and collaborators Peter Bailey, Andrea Sottoriva, and everyone supporting us through this journey Fondazione AIRC per la ricerca sul cancro, PRECODE Project, Fondazione Nadia Valsecchi ETS, Italian Pancreatic Cancer Community I-PCC,

The final #OpenAccess version of Mara Sherman Lab recent paper is now available on Cancer Discovery Stromal KITL/SCF Maintains Pancreas Tissue Homeostasis and Restrains Tumor Progression aacrjournals.org/cancerdiscover…

Research support for some of the most lethal cancers going away. This includes research into novel treatments and understanding why these are so recalcitrant to treatment, when we are slowly making progress in many other solid organ malignancies! Heading the wrong way.

Our Single Cell Genomics Day - highlighting our favorite new sc/spatial methods - starts Friday at 10AM ET! The most common question we get: is this open to anyone? Yes! Talks are free and live-streamed (no registration required) on Youtube and satijalab.org/scgd

Congratulations ⁦Anirban Maitra⁩ and ⁦Linghua Wang, MD, PhD⁩ and team for this tour de force paper just out today in Nature! What an incredible resource for understanding PDAC biology and TME ⁦⁦MD Anderson Cancer Center⁩ nature.com/articles/s4158…

datamethods.org is a place where methodologists meet subject matter experts for in-depth discussions + Q&A related to study design, measurement, data analysis, interpretation, and more. Now on a new server with the latest version of discourse software. Come join us there.

New editorial in CMGH. I highlight elegant work by Charles J Cho, 🔬🎸🚴‍♂️💻 🄼🄸🄻🄻🅂 🄻🄰🄱 and colleagues showing how blocking ribosome biogenesis in vivo disrupts acinar cell homeostasis and suppresses tumorigenesis. 🔗Editorial: cmghjournal.org/article/S2352-… 🧬Paper: cmghjournal.org/article/S2352-…

Notice of Short-Term Extension to Early-Stage Investigator (ESI) Eligibility Period grants.nih.gov/grants/guide/n…

Coming out party / preprint for Vince Bernard-Pagan, MD PHD who starts his faculty position MD Anderson Cancer Center in a week. This study identifies adaptive responses to radiation therapy in pancreatic cancer using single cell & spatial profiling, resulting in persister cell populations post XRT.

Excited to co-chair with Laura DeLong Wood Susan Tsai, MD, MHS #AndyAguirre & David Tuveson Submit your abstract!! #AACRpan25 #PancreaticCancer

A special Journal of Clinical Investigation series on #PancreaticCancer led by Ben Stanger jci.org/articles/view/… jci.org/articles/view/… jci.org/articles/view/… jci.org/articles/view/… jci.org/articles/view/… Articles by Laura DeLong Wood Muir Lab Maddipati Lab